drugset / Trial / NCT06631430
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3810477 in healthy male subjects.
Timeline
- Start
- 2024-10-30
- Primary completion
- 2025-06-12
- Completion
- 2025-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3810477 | Unknown | — | — |
Indications
No indication recorded.